306 related articles for article (PubMed ID: 17431424)
1. S-Nitrosylation and uncompetitive/fast off-rate (UFO) drug therapy in neurodegenerative disorders of protein misfolding.
Nakamura T; Lipton SA
Cell Death Differ; 2007 Jul; 14(7):1305-14. PubMed ID: 17431424
[TBL] [Abstract][Full Text] [Related]
2. Contribution of glutamatergic signaling to nitrosative stress-induced protein misfolding in normal brain aging and neurodegenerative diseases.
Nakamura T; Gu Z; Lipton SA
Aging Cell; 2007 Jun; 6(3):351-9. PubMed ID: 17388798
[TBL] [Abstract][Full Text] [Related]
3. Inflammatory mediators leading to protein misfolding and uncompetitive/fast off-rate drug therapy for neurodegenerative disorders.
Lipton SA; Gu Z; Nakamura T
Int Rev Neurobiol; 2007; 82():1-27. PubMed ID: 17678953
[TBL] [Abstract][Full Text] [Related]
4. S-nitrosylated protein-disulphide isomerase links protein misfolding to neurodegeneration.
Uehara T; Nakamura T; Yao D; Shi ZQ; Gu Z; Ma Y; Masliah E; Nomura Y; Lipton SA
Nature; 2006 May; 441(7092):513-7. PubMed ID: 16724068
[TBL] [Abstract][Full Text] [Related]
5. The chemical biology of clinically tolerated NMDA receptor antagonists.
Chen HS; Lipton SA
J Neurochem; 2006 Jun; 97(6):1611-26. PubMed ID: 16805772
[TBL] [Abstract][Full Text] [Related]
6. Redox reactions induced by nitrosative stress mediate protein misfolding and mitochondrial dysfunction in neurodegenerative diseases.
Gu Z; Nakamura T; Lipton SA
Mol Neurobiol; 2010 Jun; 41(2-3):55-72. PubMed ID: 20333559
[TBL] [Abstract][Full Text] [Related]
7. Emerging roles of S-nitrosylation in protein misfolding and neurodegenerative diseases.
Nakamura T; Lipton SA
Antioxid Redox Signal; 2008 Jan; 10(1):87-101. PubMed ID: 17961071
[TBL] [Abstract][Full Text] [Related]
8. Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders.
Sas K; Robotka H; Toldi J; Vécsei L
J Neurol Sci; 2007 Jun; 257(1-2):221-39. PubMed ID: 17462670
[TBL] [Abstract][Full Text] [Related]
9. Neuronal protection and destruction by NO.
Lipton SA
Cell Death Differ; 1999 Oct; 6(10):943-51. PubMed ID: 10556970
[TBL] [Abstract][Full Text] [Related]
10. Say NO to neurodegeneration: role of S-nitrosylation in neurodegenerative disorders.
Chung KK
Neurosignals; 2006-2007; 15(6):307-13. PubMed ID: 17901712
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological strategies for the regulation of inducible nitric oxide synthase: neurodegenerative versus neuroprotective mechanisms.
Pannu R; Singh I
Neurochem Int; 2006 Jul; 49(2):170-82. PubMed ID: 16765486
[TBL] [Abstract][Full Text] [Related]
12. Nitrosative stress in the ER: a new role for S-nitrosylation in neurodegenerative diseases.
Benhar M; Forrester MT; Stamler JS
ACS Chem Biol; 2006 Jul; 1(6):355-8. PubMed ID: 17163772
[TBL] [Abstract][Full Text] [Related]
13. A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds.
Lipton SA; Choi YB; Pan ZH; Lei SZ; Chen HS; Sucher NJ; Loscalzo J; Singel DJ; Stamler JS
Nature; 1993 Aug; 364(6438):626-32. PubMed ID: 8394509
[TBL] [Abstract][Full Text] [Related]
14. Cell death: protein misfolding and neurodegenerative diseases.
Nakamura T; Lipton SA
Apoptosis; 2009 Apr; 14(4):455-68. PubMed ID: 19130231
[TBL] [Abstract][Full Text] [Related]
15. Preventing Ca2+-mediated nitrosative stress in neurodegenerative diseases: possible pharmacological strategies.
Nakamura T; Lipton SA
Cell Calcium; 2010 Feb; 47(2):190-7. PubMed ID: 20060165
[TBL] [Abstract][Full Text] [Related]
16. Molecular mechanisms of nitrosative stress-mediated protein misfolding in neurodegenerative diseases.
Nakamura T; Lipton SA
Cell Mol Life Sci; 2007 Jul; 64(13):1609-20. PubMed ID: 17453143
[TBL] [Abstract][Full Text] [Related]
17. Protein-misfolding diseases and chaperone-based therapeutic approaches.
Chaudhuri TK; Paul S
FEBS J; 2006 Apr; 273(7):1331-49. PubMed ID: 16689923
[TBL] [Abstract][Full Text] [Related]
18. Nitric oxide, S-nitrosylation and neurodegeneration.
Chung KK; Dawson TM; Dawson VL
Cell Mol Biol (Noisy-le-grand); 2005 Sep; 51(3):247-54. PubMed ID: 16191392
[TBL] [Abstract][Full Text] [Related]
19. Lithium neuroprotection: molecular mechanisms and clinical implications.
Rowe MK; Chuang DM
Expert Rev Mol Med; 2004 Oct; 6(21):1-18. PubMed ID: 15488156
[TBL] [Abstract][Full Text] [Related]
20. Modulation of neurodegeneration by molecular chaperones.
Muchowski PJ; Wacker JL
Nat Rev Neurosci; 2005 Jan; 6(1):11-22. PubMed ID: 15611723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
